dbt Core
dbt Fusion's second beta is adapter work: ClickHouse gets materializations, indexes, and catalogs
A side-by-side editorial comparison of pharmaversesdtm and silx — release velocity, themes, recent moves, and the top alternatives to consider.
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
silx settles into maintenance a release after its PySide6 migration
silx is in the quiet phase after a generational release. 3.1.1 is a single fix to FitWidget loading a fit function from file. The release before it, 3.1.0, was the first real feature work since the migration - asinh axis scaling, twilight colormaps, and dark-theme icons - and 3.0.1 was similarly small. The 3.0.0 cut that reset the Qt binding and Python floor still defines what the line is doing.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
Two kinds of work alternate: adding domains and biomarkers for a new indication, and making the existing data easier to reach — CSV copies under inst/extdata for non-R programmers, a datasets preview vignette, reference pages categorised by therapeutic area, variable-by-variable breakdowns. Consistency fixes against CDISC terminology and SDTM guidelines run through every release.
New therapeutic areas will keep arriving in step with the admiral extension packages that need them; the neurology and metabolic datasets landed just ahead of admiralneuro and admiralmetabolic needing them, and lymphoma looks like the next in that sequence.
silx is in the quiet phase after a generational release. 3.1.1 is a single fix to FitWidget loading a fit function from file. The release before it, 3.1.0, was the first real feature work since the migration - asinh axis scaling, twilight colormaps, and dark-theme icons - and 3.0.1 was similarly small. The 3.0.0 cut that reset the Qt binding and Python floor still defines what the line is doing.
The cadence has slowed markedly since April, and the content has shifted from structural change to plotting and colormap refinement. That is the expected shape after a binding migration: downstream beamline code needs a stable target, so the project trades feature velocity for a quiet surface. The gap between 3.0.1 in May and 3.1.0 in August is the clearest signal of the deliberate slowdown.
Expect further point releases servicing the plotting and fitting widgets rather than another structural change, with feature work continuing to arrive in the 3.1.x minors rather than patches.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either pharmaversesdtm or silx.
dbt Fusion's second beta is adapter work: ClickHouse gets materializations, indexes, and catalogs
Fulcrum is betting its whole map stack on Esri, with a hard Google Maps cutoff on September 1.
Holistics keeps fencing in the AI layer it spent the summer building.
Dovetail spent July opening doors to other tools and August making its own rooms easier to enter.
The 0.0.x train stops at CRAN: tulpa's engine ships to the ecosystem it already anchors.
AgencyAI got skills three weeks ago; everything since has been making them routine.
See all pharmaversesdtm alternatives → · See all silx alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. silx is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. silx is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top pharmaversesdtm alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaversesdtm alternatives" section above for the current picks, or visit /alternatives/pharmaversesdtm for the full list with editorial commentary on each.
Top silx alternatives in Analytics are ranked by recent ship velocity. Browse the "silx alternatives" section above for the current picks, or visit /alternatives/silx for the full list with editorial commentary on each.